Canopy Growth Corp Total Liabilities

Latest as of June 2026: $415.29 Million USD

Canopy Growth Corp total liabilities. Based on the latest financial reports, Canopy Growth Corp (CGC) has total liabilities worth $415.29 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Canopy Growth Corp liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Canopy Growth Corp (2010–2026)

Total liabilities of Canopy Growth Corp from 2010 to 2026. This chart illustrates how Canopy Growth Corp's total liabilities have evolved over time, based on quarterly financial data. Explore CGC long-term investments to assets to see how much of total assets are deployed in long-term investments.

Canopy Growth Corp Competitors by Total Liabilities

The table below lists competitors of Canopy Growth Corp ranked by their total liabilities.

Company Country Total Liabilities
Nanjing Aolian Ae&Ea Co Ltd
SHE:300585
China CN¥218.44 Million
Lands’ End Inc
NASDAQ:LE
USA $456.70 Million
Ajmera Realty & Infra India Limited
NSE:AJMERA
India Rs10.75 Billion
Bhagiradha Chemicals & Industries Limited
NSE:BHAGCHEM
India Rs4.22 Billion
Anhui Sentai WPC Group Share Co. Ltd.
SHE:301429
China CN¥378.88 Million
Hydratec Industries NV
AS:HYDRA
Netherlands €110.20 Million
Tus Pharmaceutical Group Co Ltd
SHE:000590
China CN¥333.17 Million
Shenzhen Wenke Landscape Co Ltd
SHE:002775
China CN¥6.52 Billion

Liability Composition Analysis (2010–2026)

This chart breaks down Canopy Growth Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Canopy Growth Corp.

Liquidity & Leverage Metrics

Canopy Growth Corp Total Liabilities Ratios Explained

Canopy Growth Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.04 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.60 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Canopy Growth Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Canopy Growth Corp (2010–2026)

The table below shows the annual total liabilities of Canopy Growth Corp from 2010 to 2026.

Year Total Liabilities Change
2026-03-31 $421.14 Million -2.17%
2025-03-31 $430.49 Million -46.18%
2024-03-31 $799.82 Million -52.38%
2023-03-31 $1.68 Billion -15.38%
2022-03-31 $1.98 Billion -38.01%
2021-03-31 $3.20 Billion +171.28%
2020-03-31 $1.18 Billion -20.81%
2019-03-31 $1.49 Billion +669.90%
2018-03-31 $193.58 Million +207.91%
2017-03-31 $62.87 Million +221.15%
2016-03-31 $19.58 Million +207.56%
2015-03-31 $6.37 Million +48.21%
2014-12-31 $4.29 Million +225.28%
2014-03-31 $1.32 Million +12120.10%
2013-03-31 $10.80K +66.73%
2012-03-31 $6.48K -2.00%
2011-03-31 $6.61K -13.39%
2010-03-31 $7.63K --

About Canopy Growth Corp

NASDAQ:CGC USA Drug Manufacturers - Specialty & Generic
Market Cap
$275.61 Million
Market Cap Rank
#14929 Global
#3556 in USA
Share Price
$0.65
Change (1 day)
-3.58%
52-Week Range
$0.65 - $1.92
All Time High
$568.90
About

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and … Read more